Literature DB >> 7125625

Yersinia enterocolitica: comparative in vitro activities of seven new beta-lactam antibiotics.

R K Scribner, M I Marks, A Weber, C H Pai.   

Abstract

Minimum inhibitory concentrations of seven new beta-lactam derivatives were determined against 35 isolates of Yersinia enterocolitica. Ceftizoxime and ceftriaxone were the most active of the antimicrobial agents tested.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7125625      PMCID: PMC183687          DOI: 10.1128/AAC.22.1.140

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Yersinia enterocolitica infections in children.

Authors:  S Kohl; J A Jacobson; A Nahmias
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

2.  Summary of the data received at the WHO Reference Center for Yersinia enterocolitica.

Authors:  H H Mollaret; H Bercovier; J M Alonso
Journal:  Contrib Microbiol Immunol       Date:  1979

3.  Antimicrobial susceptibilities of Yersinia enterocolitica biotype 4, serotype O:3.

Authors:  S Hammerberg; S Sorger; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

4.  Yersinia enterocolitica epidemiology and antibiotic susceptibility.

Authors:  R J Fallon
Journal:  J Antimicrob Chemother       Date:  1979-05       Impact factor: 5.790

5.  Yersinia enterocolitica: in vitro antimicrobial susceptibility.

Authors:  M Raevuori; S M Harvey; M J Pickett; W J Martin
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

6.  Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

  6 in total
  13 in total

Review 1.  Yersinia enterocolitica: the charisma continues.

Authors:  E J Bottone
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 2.  Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors:  R N Brogden; A Ward
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

3.  In vitro antimicrobial susceptibilities of Yersinia enterocolitica and related species isolated from slaughtered pigs and pork products.

Authors:  J Kwaga; J O Iversen
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

4.  Faecal carriage rate of Yersinia species.

Authors:  A M Lewis; B Chattopadhyay
Journal:  J Hyg (Lond)       Date:  1986-10

5.  Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection.

Authors:  M R Scavizzi; J M Alonso; A M Philippon; A M Jupeau-Vessieres; A Guiyoule
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

6.  Failure of beta-lactam antibiotics and marked efficacy of fluoroquinolones in treatment of murine Yersinia pseudotuberculosis infection.

Authors:  B C Lemaitre; D A Mazigh; M R Scavizzi
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 7.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

8.  Antimicrobial susceptibilities of food-isolated strains of Yersinia enterocolitica, Y. intermedia, Y. frederiksenii, and Y. kristensenii.

Authors:  A Ahmedy; D J Vidon; C L Delmas; M C Lett
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

Review 9.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

10.  In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics.

Authors:  M J Hornstein; A M Jupeau; M R Scavizzi; A M Philippon; P A Grimont
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.